ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Lack of validated blood pressure devices for use in pregnancy available from Australian pharmacies.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood pressure monitoring is a critical aspect of prenatal care, as hypertension during pregnancy can lead to serious complications such as preeclampsia, eclampsia, and other hypertensive disorders. Automatic blood pressure devices are widely used for home monitoring due to their convenience and ease of use. The use of validated automated blood pressure monitors is recommended by the International Society of Hypertension for home blood pressure measurements, and automatic devices require accuracy validation among people who are pregnant before they are recommended for use in pregnancy. This study evaluated availability of such devices from 18 Australian pharmacies. Only four devices (4/54, 7%) were validated for pregnancy and were more expensive than devices validated for the general population (14/54, 26%) and non-validated devices (40/54, 74%). Additionally, limited labelling and information was available to assist consumers to make informed purchasing decisions about home blood pressure devices for use in pregnancy. Increased availability, clear labelling and consumer education could help ensure use of appropriate blood pressure devices in pregnancy. Automatic blood pressure devices require additional accuracy validation for use in pregnancy. We found only four devices (4/54, 7%) were validated for pregnancy, which were more expensive than non-validated devices. Increased education could help ensure use of appropriate blood pressure devices in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.